1. Resistance to MET inhibition in MET-dependent NSCLC and therapeutic activity after switching from type I to type II MET inhibitors. (January 2023) Authors: Riedel, Richard; Fassunke, Jana; Tumbrink, Hannah L.; Scheel, Andreas H.; Heydt, Carina; Hieggelke, Lena; Scheffler, Matthias; Heimsoeth, Alena; Nogova, Lucia; Michels, Sebastian; Weber, Jan-Phillip; Fischer, Rieke N.; Eisert, Anna; Westphal, Theresa; Schaufler, Diana; Siemanowski, Janna; Ihle, M... Journal: European journal of cancer Issue: Volume 179(2023) Page Start: 124 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗